Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force guidelines

被引:38
作者
Anderson, HV
Shaw, RE
Brindis, RG
Klein, LW
McKay, CR
Kutcher, MA
Krone, RJ
Wolk, MJ
Smith, SC
Weintraub, WS
机构
[1] Univ Texas, Hlth Sci Ctr, Div Cardiol, Houston, TX 77030 USA
[2] Sutter Pacific Heart Ctr, San Francisco, CA USA
[3] Kaiser Permanente Hlth Syst, Oakland, CA USA
[4] Rush Med Coll, Chicago, IL 60612 USA
[5] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[6] Wake Forest Univ, Winston Salem, NC 27109 USA
[7] Washington Univ, St Louis, MO USA
[8] Cornell Med Ctr, New York, NY USA
[9] Univ N Carolina, Chapel Hill, NC USA
[10] Emory Univ, Atlanta, GA 30322 USA
关键词
angioplasty; coronary disease; mortality; registries; stents;
D O I
10.1161/CIRCULATIONAHA.105.553727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: An American College of Cardiology/American Heart Association (ACC/AHA) Task Force periodically revises and publishes guidelines with evidence-based recommendations for appropriate use of percutaneous coronary intervention (PCI). Some studies have suggested that closer adherence to guidelines can reduce variations in care, can improve quality, and may ultimately result in better outcomes, but this finding is incompletely understood. Guidelines themselves must change to be responsive to continuously evolving clinical practice. Our goal here was to investigate whether any relationship existed between the most recent ACC/AHA recommended indications for PCI and short term in- hospital outcomes. Methods and Results: We analyzed the ACC National Cardiovascular Data Registry for the period of January 1, 2001, through March 31, 2004. We excluded PCI procedures performed for acute myocardial infarction (ST- segment elevation myocardial infarction); all others were grouped by their indications according to the standard ACC/AHA scheme: Class I, evidence and/or agreement that PCI is useful and effective; Class IIa, conflicting evidence and/or divergent opinions, weight is in favor; Class IIb, usefulness/efficacy is less well established; and Class III, evidence and/or agreement that PCI is not useful or effective and may be harmful. Clinical success was defined as angiographic success (< 20% residual stenosis) at all lesions attempted without the adverse events of myocardial infarction, same- admission bypass surgery, or death. There were 412 617 PCI procedures included in the analysis. Frequency of indications was as follows: Class I, 64%; Class IIa, 21%; Class IIb, 7%; and Class III, 8%. Clinical success declined across the indications classes (92.8%, 91.7%, 89%, and 85.5%, respectively; P < 0.001), whereas adverse events increased. Conclusions: In this large survey of contemporary PCI practice, most procedures were performed for Class I indications. A significant relationship between evidence-based indications recommended by the ACC/AHA Task Force and in-hospital outcomes was noted.
引用
收藏
页码:2786 / 2791
页数:6
相关论文
共 15 条
  • [1] A contemporary overview of percutaneous coronary interventions - The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)
    Anderson, HV
    Shaw, RE
    Brindis, RG
    Hewitt, K
    Krone, RJ
    Block, PC
    McKay, CR
    Weintraub, WS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) : 1096 - 1103
  • [2] Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes - Results from the CRUSADE quality improvement initiative
    Bhatt, DL
    Roe, MT
    Peterson, ED
    Li, Y
    Chen, AY
    Harrington, RA
    Greenbaum, AB
    Berger, PB
    Cannon, CP
    Cohen, DJ
    Gibson, CM
    Saucedo, JF
    Kleiman, NS
    Hochman, JS
    Boden, WE
    Brindis, RG
    Peacock, WF
    Smith, SC
    Pollack, CV
    Gibler, WB
    Ohman, EM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (17): : 2096 - 2104
  • [3] Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9
  • [4] Integrating quality into the cycle of therapeutic development
    Califf, RM
    Peterson, ED
    Gibbons, RJ
    Garson, A
    Brindis, RG
    Beller, GA
    Smith, SC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (11) : 1895 - 1901
  • [5] American college of cardiology/american heart association clinical practice guidelines: Part I - Where do they come from?
    Gibbons, RJ
    Smith, S
    Antman, E
    [J]. CIRCULATION, 2003, 107 (23) : 2979 - 2986
  • [6] American College of Cardiology American Heart Association clinical practice guidelines: Part II - Evolutionary changes in a continuous quality improvement project
    Gibbons, RJ
    Smith, SC
    Antman, E
    [J]. CIRCULATION, 2003, 107 (24) : 3101 - 3107
  • [7] Outcomes, health policy, and managed care - Adherence to practice guidelines: The role of specialty society guidelines
    Leape, LL
    Weissman, JS
    Schneider, EC
    Piana, RN
    Gatsonis, C
    Epstein, AM
    [J]. AMERICAN HEART JOURNAL, 2003, 145 (01) : 19 - 26
  • [8] Enhancing quality of care for acute myocardial infarction: Shifting the focus of improvement from key indicators to process of care and tool use
    Mehta, RH
    Montoye, CK
    Faul, J
    Nagle, DJ
    Kure, J
    Raj, E
    Fattal, P
    Sharrif, S
    Amlani, M
    Changezi, HU
    Skorcz, S
    Bailey, N
    Bourque, T
    LaTarte, M
    McLean, D
    Savoy, S
    Werner, P
    Baker, PL
    DeFranco, A
    Eagle, KA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 2166 - 2173
  • [9] Development of a risk adjustment mortality model using the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000
    Shaw, RE
    Anderson, HV
    Brindis, RG
    Krone, RJ
    Klein, LW
    McKay, CR
    Block, PC
    Shaw, LJ
    Hewitt, K
    Weintraub, WS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) : 1104 - 1112
  • [10] Shaw Richard E, 2003, J Invasive Cardiol, V15, P578